Wells Fargo & Company Ark Genomic Revolution ETF (De Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
A detailed history of Wells Fargo & Company transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Wells Fargo & Company holds 1,288,225 shares of ARKG stock, worth $29.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,288,225
Previous 1,291,740
0.27%
Holding current value
$29.9 Million
Previous $30.3 Million
8.73%
% of portfolio
0.01%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding ARKG
# of Institutions
287Shares Held
24.5MCall Options Held
3.02MPut Options Held
2.65M-
Jpmorgan Chase & CO New York, NY2.96MShares$68.6 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC2.9MShares$67.4 Million0.01% of portfolio
-
Main Management ETF Advisors, LLC San Francisco, CA2.43MShares$56.4 Million2.95% of portfolio
-
Goldman Sachs Group Inc New York, NY1.81MShares$42.1 Million0.01% of portfolio
-
Citigroup Inc1.68MShares$39 Million0.03% of portfolio